Literature DB >> 17172838

Histone H3 lysine 56 acetylation: a new twist in the chromosome cycle.

Anil Ozdemir1, Hiroshi Masumoto, Paul Fitzjohn, Alain Verreault, Colin Logie.   

Abstract

Several recent reports have identified lysine 56 (K56) as a novel site of acetylation in yeast histone H3. K56 acetylation is predicted to disrupt some of the histone-DNA interactions at the entry and exit points of the nucleosome core particle. This modification occurs in virtually all the newly synthesised histones that are deposited into chromatin during S-phase. Cells with mutations that block K56 acetylation show increased genome instability and hypersensitivity to genotoxic agents that interfere with replication. Removal of K56 acetylation takes place in the G2/M phase of the cell cycle and is dependent upon Hst3 and Hst4, two proteins that are related to the NAD+-dependent histone deacetylase Sir2. In response to DNA damage checkpoint activation during S-phase, expression of Hst3/Hst4 is delayed to extend the window of opportunity in which K56 acetylation can act in the DNA damage response. The high abundance of histone H3 K56 acetylation, its regulation and strategic location in the nucleosome core particle raise a number of fascinating issues that we discuss here.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17172838     DOI: 10.4161/cc.5.22.3473

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  31 in total

Review 1.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

2.  Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control.

Authors:  Seema Somji; Scott H Garrett; Xu Dong Zhou; Yun Zheng; Donald A Sens; Mary Ann Sens
Journal:  Toxicol Environ Chem       Date:  2010-10       Impact factor: 1.437

3.  Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells.

Authors:  Chiara Conti; Barbara Saccà; John Herrick; Claude Lalou; Yves Pommier; Aaron Bensimon
Journal:  Mol Biol Cell       Date:  2007-05-23       Impact factor: 4.138

4.  Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum.

Authors:  Adriana M Salcedo-Amaya; Marc A van Driel; Blaise T Alako; Morten B Trelle; Antonia M G van den Elzen; Adrian M Cohen; Eva M Janssen-Megens; Marga van de Vegte-Bolmer; Rebecca R Selzer; A Leonardo Iniguez; Roland D Green; Robert W Sauerwein; Ole N Jensen; Hendrik G Stunnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

5.  Probing nucleosome function: a highly versatile library of synthetic histone H3 and H4 mutants.

Authors:  Junbiao Dai; Edel M Hyland; Daniel S Yuan; Hailiang Huang; Joel S Bader; Jef D Boeke
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

Review 6.  Chromatin dynamics: interplay between remodeling enzymes and histone modifications.

Authors:  Sarah G Swygert; Craig L Peterson
Journal:  Biochim Biophys Acta       Date:  2014-02-28

7.  The Rtt109 histone acetyltransferase facilitates error-free replication to prevent CAG/CTG repeat contractions.

Authors:  Jiahui H Yang; Catherine H Freudenreich
Journal:  DNA Repair (Amst)       Date:  2010-01-18

8.  Schizosaccharomyces pombe Hst4 functions in DNA damage response by regulating histone H3 K56 acetylation.

Authors:  Devyani Haldar; Rohinton T Kamakaka
Journal:  Eukaryot Cell       Date:  2008-03-14

9.  Histone H3 serine 57 and lysine 56 interplay in transcription elongation and recovery from S-phase stress.

Authors:  Aamir Aslam; Colin Logie
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

10.  The elongator complex interacts with PCNA and modulates transcriptional silencing and sensitivity to DNA damage agents.

Authors:  Qing Li; A M Fazly; Hui Zhou; Shengbing Huang; Zhiguo Zhang; Bruce Stillman
Journal:  PLoS Genet       Date:  2009-10-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.